H. Motoyama

发表

Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2019, Clinical journal of gastroenterology.

Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C

A. Tamori, A. Hagihara, N. Kawada, 2018, United European gastroenterology journal.

The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor‐naïve patients with chronic HCV genotype 1b infection in a real‐world cohort

A. Tamori, A. Hagihara, N. Kawada, 2018, Journal of viral hepatitis.

Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b

A. Tamori, A. Hagihara, N. Kawada, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use

A. Tamori, A. Hagihara, N. Kawada, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway.

A. Tamori, K. Yoshizato, S. Kubo, 2015, The American journal of pathology.

Tumorigenesis and Neoplastic Progression Promotion of Liver and Lung Tumorigenesis in DEN-Treated Cytoglobin-Deficient Mice

K. Wakasa, K. Yoshizato, N. Kawada, 2011 .

Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication

A. Tamori, A. Hagihara, S. Kubo, 2018, PloS one.

Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver

A. Tamori, A. Hagihara, K. Yoshizato, 2014, Laboratory Investigation.

A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites

H. Yoshiji, M. Nojima, H. Sawai, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.

A. Tamori, A. Hagihara, N. Kawada, 2020, Annals of hepatology.

GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Cytoglobin De fi ciency Promotes Liver Cancer Development from Hepatosteatosis through Activation of the Oxidative Stress Pathway

A. Tamori, K. Yoshizato, S. Kubo, 2022 .

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma

A. Tamori, A. Hagihara, S. Kubo, 2022, JGH open : an open access journal of gastroenterology and hepatology.

Association between HLA‐DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment

A. Tamori, A. Hagihara, N. Kawada, 2018, Journal of gastroenterology and hepatology.

Interferon‐gamma–mediated tissue factor expression contributes to T‐cell‐mediated hepatitis through induction of hypercoagulation in mice

D. Kirchhofer, N. Kawada, J. Fujimoto, 2013, Hepatology.

Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment

A. Tamori, A. Hagihara, N. Kawada, 2021, Journal of viral hepatitis.

Promotion of intra-hospital referral of hepatitis B and C virus carriers to hepatology specialists by electronic medical record-based alert system: a case study at a university hospital

A. Tamori, A. Hagihara, N. Kawada, 2016 .

Induction of microRNA-214-5p in human and rodent liver fibrosis

Kazuo Ikeda, Katsutoshi Yoshizato, Tomohiro Ogawa, 2012, Fibrogenesis & tissue repair.

A case of hepatocellular carcinoma with “pseudoprogression” followed by complete response to atezolizumab plus bevacizumab

A. Tamori, A. Hagihara, N. Kawada, 2023, Clinical Journal of Gastroenterology.

Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis

A. Tamori, A. Hagihara, N. Kawada, 2023, Journal of Gastroenterology.

Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.

A. Tamori, A. Hagihara, N. Kawada, 2017, Annals of hepatology.

Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed

A. Tamori, A. Hagihara, N. Kawada, 2017, International journal of molecular sciences.

A case of hepatitis C virus-associated mixed cryoglobulinemic vasculitis treated with daclatasvir and asunaprevir

A. Tamori, A. Hagihara, N. Kawada, 2016 .

Could Trastuzumab Suppress Hepatitis C Virus in a Patient With Chronic Hepatitis and Breast Cancer?

A. Tamori, N. Kawada, K. Hirakawa, 2011, The American Journal of Gastroenterology.

Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment

A. Tamori, A. Hagihara, N. Kawada, 2021, Scientific reports.

[Drug-induced liver injury caused by an herbal medicine, bofu-tsu-sho-san].

A. Tamori, N. Kawada, H. Fujii, 2008, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy

A. Tamori, A. Hagihara, N. Kawada, 2017, Journal of gastroenterology and hepatology.

Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.

A. Tamori, A. Hagihara, N. Kawada, 2017, Annals of hepatology.

Risk factors for liver‐related and non‐liver‐related mortality following a sustained virological response after direct‐acting antiviral treatment for hepatitis C virus infection in a real‐world cohort

A. Tamori, A. Hagihara, N. Kawada, 2022, Journal of Viral Hepatitis.

Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease

A. Hagihara, N. Kawada, Kohei Kotani, 2023, Nutrients.

ITPA polymorphism correlates with the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy

A. Tamori, A. Hagihara, N. Kawada, 2017 .